Results 251 to 260 of about 107,923 (299)
Some of the next articles are maybe not open access.

Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal of Vascular and Interventional Radiology, 2020
A formal systematic review and study-level meta-analysis of randomized controlled trials investigating treatment of the infrapopliteal arteries with paclitaxel-coated balloons compared with conventional balloon angioplasty for critical limb ischemia (CLI)
K. Katsanos   +5 more
semanticscholar   +1 more source

Critical Limb Ischemia

Annals of Vascular Surgery, 2000
Critical limb ischemia (CLI) is defined as a condition that endangers all or part of the limb if no radical improvement in blood flow can be achieved by means of surgery, interventional radiology, or medical treatment163 (Figure 42.1).
Leonella Pasqualini, Elmo Mannarino
openaire   +2 more sources

Critical limb ischemia

Current Treatment Options in Cardiovascular Medicine, 2007
Critical limb ischemia (CLI) is the most severe manifestation of peripheral artery disease (PAD). Without timely recognition, appropriate diagnosis, and revascularization, patients with CLI are at risk for amputation or potentially fatal complications.
David L, Dawson, Joseph L, Mills
openaire   +2 more sources

Critical Limb Ischemia

Cardiology Clinics, 2015
Critical limb ischemia (CLI), the most advanced form of peripheral artery disease (PAD), carries grave implications with regard to morbidity and mortality. Within 1 year of CLI diagnosis, 40% to 50% of diabetics will experience an amputation, and 20% to 25% will die. Management is optimally directed at increasing blood flow to the affected extremity to
Sarah, Elsayed, Leonardo C, Clavijo
openaire   +2 more sources

Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis

Vascular Medicine, 2020
High-intensity statins are recommended for patients with peripheral artery disease (PAD). Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins in the CLI population is unclear based on the existent studies.
D. Kokkinidis   +10 more
semanticscholar   +1 more source

Critical Limb Ischemia

2017
Patients with CLI have a poor prognosis, the estimated 3-year probability of mortality being 35.1%. As a result, preference to less burdensome endovascular treatment should be given, provided the same levels of symptomatic improvement can be achieved as with open surgery.
Suparna Rao   +2 more
  +4 more sources

Understanding critical limb ischemia

Nursing, 2008
Find out how to halt this progression of peripheral arterial disease before it jeopardizes life and limb.
openaire   +3 more sources

Notable Racial and Ethnic Disparities Persist in Lower Extremity Amputations for Critical Limb Ischemia and Infection.

Journal of the American Academy of Orthopaedic Surgeons, 2020
INTRODUCTION The purpose of this study is to investigate the current disparities for major lower extremity amputation in patients with critical limb ischemia (CLI) and infection.
Sophia A. Traven   +5 more
semanticscholar   +1 more source

Critical Limb Ischemia

Surgical Clinics of North America, 2013
Critical limb ischemia refers to the clinical state of advanced arterial occlusive disease, placing an extremity at risk for gangrene and limb loss. Critical limb ischemia has 2 broad clinical subcategories that are vital to differentiate: acute limb ischemia and chronic arterial occlusive disease.
openaire   +2 more sources

Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

Journal of the American College of Cardiology, 2018
BACKGROUND Critical limb ischemia (CLI) is the most serious complication of peripheral artery disease (PAD). OBJECTIVES The purpose of this study was to characterize pathology of PAD in below- and above-knee amputation specimens in patients presenting ...
N. Narula   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy